Posted by Michael Wonder on 24 Jun 2021
TGA grants provisional determination for the Moderna COVID-19 vaccine, Elasomeran
24 June 2021 - Today, the Therapeutic Goods Administration granted provisional determination to Moderna Australia in relation to the COVID-19 Vaccine, Elasomeran.
This mRNA vaccine will be considered for the active immunisation to prevent coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, in individuals aged 12 years of age and older.
